Together we will beat cancer

Donate now

Institute

Showing 12 out of 39 results
A researcher looking at slides under a microscope

Michelle Mitchell, our chief executive, talks about why the charity's recent investment into research in Scotland is so important Michelle Mitchell, our chief executive, talks about why the charity's recent investment into research in Scotland is so important

by Michelle Mitchell | Opinion | 21 September 2023

21 September 2023

CRUK Scotland Institute

Today we announced our largest ever investment in Scotland of up to £123m as part of a seven-year commitment to the Cancer Research UK Scotland Institute Today we announced our largest ever investment in Scotland of up to £123m as part of a seven-year commitment to the Cancer Research UK Scotland Institute

by Amy Warnock | News | 20 September 2023

20 September 2023

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023

Lung adenocarcinoma cells

Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers. Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers.

by Jacob Smith | Analysis | 1 June 2023

1 June 2023

Breast magnetic resonance image, or MRI. The bright white dot in the larger images is stage one breast cancer.

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

by Jacob Smith | Analysis | 9 May 2023

9 May 2023

Picture of the new Cancer Research UK Manchester Institute

Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place. Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place.

by Martin McGlown | Opinion | 26 April 2023

26 April 2023

Non small cell lung cancer cells stained in pleural effusion sample.

Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment. Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment.

by Jacob Smith | Analysis | 12 April 2023

12 April 2023

Melanoma cells viewed under the microscope

New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life. New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life.

by Jacob Smith | News | 29 March 2023

29 March 2023

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022